Intraocular lenses: experience at The Wilmer Institute.
Intraocular lenses: experience at The Wilmer Institute.
复制标题
人工晶状体：威尔默研究所的经验。
DOI：
--
复制
发表时间：
1983
期刊：
影响因子：
--
通讯作者：
MANUEL B. DATILES Md
中科院分区：
文献类型：
--
作者：
WALTER J. STARK Md;A. Md;WARREN R. FAGADAU Md;LAWRENCE W. HIRST Md;MANUEL B. DATILES Md
回顾了在过去六年中由两位外科医生在威尔默研究所进行的938例连续的初次人工透镜（IOL）植入病例。在Morcher（欧洲）四环虹膜夹Binkhorst IOL组中检测到进行性角膜内皮细胞丢失和迟发性角膜水肿发生率增加。在植入美国制造的四环Binkhorst透镜的眼睛中，发生临床显著性囊样黄斑水肿的发生率更高，可能是由于IOL上的污染物引起的慢性虹膜炎。我们在囊外白内障摘除术时植入美国制造的剪切型IOL的短期结果令人鼓舞，96%的病例达到20/40视力或更好，不包括已知的黄斑变性或弱视患者。提交给美国食品药品监督管理局（FDA）的数据分析表明，四类人工晶状体（前房、瞳孔支撑、虹膜囊膜和后房）中的大多数在1年随访时安全有效。在过去的三年中，人们对植入的IOL类型的偏好逐渐发生了变化-从瞳孔支撑型和虹膜囊型IOL，部分从前房IOL到后房IOL。建议继续采用保守方法植入IOL。
Nine hundred and thirty-eight consecutive primary intraocular lens (IOL) implant cases performed at The Wilmer Institute during the past six years by two surgeons were reviewed. Progressive corneal endothelial cell loss and an increased rate of late-onset corneal oedema were detected in the group with the Morcher (European) four-loop iris-clip Binkhorst IOLs. A higher rate of clinically-significant cystoid macular oedema developed in eyes with the American-manufactured four-loop Binkhorst lens, presumably from chronic iritis caused by contaminants on the IOLs. Our short-term results with the American-manufactured Shearing-type IOLs implanted at the time of extracapsular cataract extraction are encouraging, with 96% of cases achieving 20/40 vision or better, excluding those with known macular degeneration or amblyopia. Analysis of data submitted to the United States Food and Drug Administration (FDA) indicates that most of the four classes of intraocular lenses (anterior chamber, pupillary-supported, iridocapsular, and posterior chamber) are safe and effective at one-year follow-up. During the past three years there has been a gradual shift of preference in the type of IOLs being implanted--away from pupillary-supported and iridocapsular IOLs and, in part, from anterior chamber IOLs, to posterior chamber IOLs. A continued conservative approach to IOL implantation is recommended.